TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

UnitedHealth Preview Was Mixed; So Where Is the Spot to Buy the Dip?
Play
INVESTING

Biogen, UnitedHealth: 5 Top Stock Gainers for Wednesday

  • By Rob Lenihan
  • Nov 4, 2020 4:27 PM EST
PRESS RELEASES

Neurocrine Biosciences To Present At The 39th Annual J.P. Morgan Healthcare Conference

  • By PR Newswire
  • Jan 4, 2021 4:01 PM EST
PRESS RELEASES

Neurocrine Biosciences To Present At Upcoming Healthcare Conferences

  • By PR Newswire
  • Nov 19, 2020 9:00 AM EST
PRESS RELEASES

Neurocrine Biosciences Announces Repurchase Of Convertible Notes

  • By PR Newswire
  • Nov 19, 2020 8:00 AM EST
PRESS RELEASES

Neurocrine Biosciences To Present At Upcoming Healthcare Conferences

  • By PR Newswire
  • Nov 9, 2020 9:00 AM EST
UnitedHealth Preview Was Mixed; So Where Is the Spot to Buy the Dip?
INVESTING

Biogen, UnitedHealth: 5 Top Stock Gainers for Wednesday

  • By Rob Lenihan
  • Nov 4, 2020 4:27 PM EST
PRESS RELEASES

Neurocrine Biosciences Announces Conference Call And Webcast Of Third Quarter 2020 Financial Results

  • By PR Newswire
  • Oct 6, 2020 4:01 PM EDT
PRESS RELEASES

Neurocrine Biosciences To Present New Data Analyses Of Once-Daily ONGENTYS® (opicapone) In Patients With Parkinson's Disease At The American Neurological Association 2020 Virtual Meeting

  • By PR Newswire
  • Sep 28, 2020 4:01 PM EDT
PRESS RELEASES

Neurocrine Biosciences Announces Once-Daily ONGENTYS® (opicapone) Now Available In The U.S. As An Add-On Treatment For Patients With Parkinson's Disease Experiencing "Off" Episodes

  • By PR Newswire
  • Sep 14, 2020 8:44 AM EDT
PRESS RELEASES

Neurocrine Biosciences To Present At The Morgan Stanley 18th Annual Global Healthcare Conference

  • By PR Newswire
  • Sep 8, 2020 4:01 PM EDT
PRESS RELEASES

Neurocrine Biosciences To Present New Data From Its Movement Disorder Programs For Tardive Dyskinesia And Parkinson's Disease At Upcoming Scientific Meetings

  • By PR Newswire
  • Sep 3, 2020 4:06 PM EDT
PRESS RELEASES

Neurocrine Biosciences To Present At The Citi 15th Annual BioPharma Virtual Conference

  • By PR Newswire
  • Sep 2, 2020 4:01 PM EDT
Wake Up Wall Street: Markets Cautious Ahead of Trump's China Meeting
JIM CRAMER

Weed Out the Losers: Cramer's 'Mad Money' Recap (Thursday 8/20/20)

  • By Scott Rutt
  • Aug 20, 2020 7:59 PM EDT
PRESS RELEASES

Neurocrine Biosciences To Participate At The William Blair Biotech Focus Conference 2020

  • By PR Newswire
  • Jul 30, 2020 4:01 PM EDT
PRESS RELEASES

Neurocrine Biosciences Announces Conference Call And Webcast Of Second Quarter 2020 Financial Results

  • By PR Newswire
  • Jul 13, 2020 4:01 PM EDT
PRESS RELEASES

Neurocrine Biosciences And Takeda Announce Collaboration To Develop And Commercialize Potential Therapies For Psychiatric Disorders

  • By Business Wire
  • Jun 16, 2020 7:00 AM EDT
PRESS RELEASES

Neurocrine Biosciences To Present At The Bank Of America Securities 2020 Napa Biopharma Conference

  • By PR Newswire
  • Jun 15, 2020 4:01 PM EDT
PRESS RELEASES

Neurocrine Biosciences To Present At The Goldman Sachs 41st Annual Global Healthcare Conference Webcast

  • By PR Newswire
  • Jun 4, 2020 4:01 PM EDT
PRESS RELEASES

Neurocrine Biosciences To Present At The Jefferies Virtual Healthcare Conference

  • By PR Newswire
  • May 26, 2020 4:01 PM EDT
PRESS RELEASES

Neurocrine Biosciences To Present At The RBC Capital Markets 2020 Global Healthcare Conference

  • By PR Newswire
  • May 14, 2020 7:29 PM EDT
PRESS RELEASES

Neurocrine Biosciences Exercises Option To License Idorsia's Novel Treatment For Rare Pediatric Epilepsy

  • By PR Newswire
  • May 11, 2020 4:01 PM EDT
PRESS RELEASES

Neurocrine Biosciences To Present At Bank Of America Merrill Lynch Health Care Conference 2020

  • By PR Newswire
  • May 5, 2020 4:01 PM EDT
Biotech Movers: Inovio, Neurocrine, Alnylam
INVESTING

Neurocrine Biosciences Parkinson's Drug Cleared by FDA

  • By Dan Weil
  • Apr 27, 2020 11:07 AM EDT
PRESS RELEASES

Neurocrine Biosciences Announces FDA Approval Of Once-Daily ONGENTYS® (opicapone) As An Add-On Treatment For Patients With Parkinson's Disease Experiencing "Off" Episodes

  • By PR Newswire
  • Apr 27, 2020 7:30 AM EDT
PRESS RELEASES

Neurocrine Biosciences Announces Conference Call And Webcast Of First Quarter 2020 Financial Results

  • By PR Newswire
  • Apr 15, 2020 4:01 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.